Nancy Turman

Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients

Nabeel Jabri, Sherwyn Schwartz, Jerome S. Fischer et al. · Diabetes · 1994 · 112 citations

Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus.

Nancy Turman, Victoria S Marcsisin, Michael Heffernan et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 52 citations

Nutrition, Type Ii, Insulin Signaling +17

Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome

Adam M. Petrich, Brad S. Kahl, Howard H. Bailey et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 28 citations · Full text

A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas

Lisa Kujawski, Walter Longo, Eliot C. Williams et al. · Cancer Investigation · 2007 · 19 citations

Neuro-oncology, Lymphoid Neoplasia, Oncology +15

Phase II Study of Weekly Low-Dose Paclitaxel for Relapsed and Refractory Non-Hodgkin's Lymphoma: A Wisconsin Oncology Network Study

Brad S. Kahl, Howard H. Bailey, KyungMann Kim et al. · Cancer Investigation · 2005 · 18 citations

Lymphoid Neoplasia, Oncology, Refractory Non-hodgkin +15